36 results
8-K
EX-99.1
NMTC
NeuroOne Medical Technologies Corp
15 Dec 21
NeuroOne Reports Fourth Fiscal Quarter and Full Fiscal Year 2021
8:15am
and development catalysts and a product pipeline targeting multi-billion-dollar markets, underpinning our unwavering commitment to driving shareholder value
8-K
EX-10.1
NMTC
NeuroOne Medical Technologies Corp
4 Oct 21
Other Events
4:48pm
be.
(e) Change in Time Commitment. In the event a Participant’s regular level of time commitment in the performance of his or her services … portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y) in lieu of or in combination
8-K
EX-10.1
NMTC
NeuroOne Medical Technologies Corp
15 Jan 21
NeuroOne Medical Technologies Corporation Announces Private Placement
8:08am
or other agreement, instrument or commitment to which the Company is a party or by which they or their respective properties are bound; or (iv) any … of capital stock or other equity interest in the Company, or any contract, commitment, agreement, understanding or arrangement of any kind to which
8-K
EX-10.1
NMTC
NeuroOne Medical Technologies Corp
3 Aug 20
Entry into a Material Definitive Agreement
4:17pm
.
“Voting Commitment” shall have the meaning ascribed to such term in Section 4.2(a).
ARTICLE 2
PURCHASE AND SALE
2.1 Purchase and Sale. Subject … any commitment or assurance to, any Person as to how such Person, if serving as a director or if elected as a director of the Corporation, will act
8-K
EX-10.1
NMTC
NeuroOne Medical Technologies Corp
22 Jul 20
Entry into a Material Definitive Agreement
8:13am
during the SEEG Exclusive License Period, or make any commitment or enter into any contract, license or agreement that would conflict with, frustrate
8-K
EX-99.1
txpaxtgbc6k9wfqk
2 Dec 19
NeuroOne Medical Technologies Corporation Receives FDA 510(k) Clearance for Evo™ Cortical Electrode
9:09am
8-K
EX-10.1
pa9mc
29 Oct 19
Entry into a Material Definitive Agreement
4:56pm
424B3
w5236u6g
19 Aug 19
Prospectus supplement
4:17pm
10-KT/A
e9q h2tqqp8yt
18 Mar 19
Annual report (with FYE transition) (amended)
12:00am
10-KT/A
EX-99.1
bf1d4ron
18 Mar 19
Annual report (with FYE transition) (amended)
12:00am
424B3
vcp5dfksl6jg
7 Mar 19
Prospectus supplement
12:00am
424B3
m01 lqnxbsf53t70gfjy
8 Feb 19
Prospectus supplement
1:19pm
8-K
EX-10.1
dueqw81ij682b
4 Jan 19
Entry into a Material Definitive Agreement
4:16pm
10-KT
zdqsfs3
12 Dec 18
Annual report (with FYE transition)
9:10am
10-KT
EX-99.1
62d6k
12 Dec 18
Annual report (with FYE transition)
9:10am